¼¼°èÀÇ ½ÅÁú¼ö¼ú ½ÃÀå
Neovaginal Surgery
»óǰÄÚµå : 1787223
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,229,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,687,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ½ÅÁú¼ö¼ú ½ÃÀåÀº 2030³â±îÁö 15¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 12¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ½ÅÁú¼ö¼ú ½ÃÀåÀº 2030³â¿¡´Â 15¾ï ´Þ·¯¿¡ ´ÞÇϸç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 3.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¼ºº° ÀûÇÕ ¼ö¼úÀº CAGR 3.6%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 8¾ï 3,790¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÁúÇü¼º ºÎÀü Ä¡·á ¼ö¼ú ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 4.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3¾ï 3,300¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½ÅÁú¼ö¼ú ½ÃÀåÀº 2024³â¿¡ 3¾ï 3,300¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀ» 7.1%·Î, 2030³â±îÁö 3¾ï 990¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.6%¿Í 3.0%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ½Å Áú ¼ö¼ú ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

Çö´ë ÀÇÇп¡¼­ ½ÅÁú ¼ö¼úÀÌ Á¡Á¡ ´õ Áß¿äÇØÁö´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

Áú Àç°Ç ¼ö¼úÀº Àç°Ç ¼ö¼ú°ú ¼ºÀüȯ ¼ö¼úÀÇ °íµµ·Î Àü¹®È­µÈ ºÐ¾ß·Î, ÀÇÇÐÀÇ ¹ßÀüÀ¸·Î Áú Àç°ÇÀÌ ÇÊ¿äÇÑ »ç¶÷µéÀÇ ¼±ÅñÇÀÌ ³Ð¾îÁü¿¡ µû¶ó ±× Á߿伺ÀÌ Á¡Á¡ ´õ Ä¿Áö°í ÀÖ½À´Ï´Ù. ÀÌ ¼ö¼úÀº Æ®·£½ºÁ¨´õ ¿©¼ºÀÇ ¼ºº° È®ÀÎ ¼ö¼ú, ¸ÞÀ̾î-·ÎÅ©ÅϽºÅ°-Äí½ºÅÍ-ÇÏ¿ìÀú(MRKH) ÁõÈıº°ú °°Àº ¼±Ãµ¼º Áúȯ, ¿Ü»óÀ̳ª Á¾¾ç Ä¡·á ÈÄ Àç°Ç ÇÊ¿ä µî ´Ù¾çÇÑ ÀÇÇÐÀû, °³ÀÎÀû ÀÌÀ¯·Î ½ÃÇàµÇ°í ÀÖ½À´Ï´Ù. ¼ö¼ú ±â¹ýÀÇ ¹ßÀüÀ¸·Î À½°æ¹ÝÀüÁú¼ºÇü¼ú, ÀåÁú¼ºÇü¼ú, Á¶Á÷È®Àå¼ú, ÀÚ°¡ÇǺÎÀ̽ÄÀ» ÀÌ¿ëÇÑ Áú¼ºÇü¼ú°ú °°Àº ºñ¼ö¼úÀû ¹æ¹ý±îÁö ´Ù¾çÇÑ Á¢±Ù¹ýÀ¸·Î Ä¡·á ¼ºÀûÀÌ ´«¿¡ ¶ç°Ô Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¼ö¼ú Àç·á¿Í ¼ö¼ú ÈÄ °ü¸®ÀÇ ¹ßÀüÀ¸·Î ±â´É¼º, ½É¹ÌÀû °á°ú, ȯÀÚ ¸¸Á·µµ°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. Æ®·£½ºÁ¨´õ Çì¾îÄɾ ´ëÇÑ ¼ö¿ë°ú ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÅÁú¼ºÇü¼ú¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ ÀÇ·á ºÐ¾ßÀÇ Àü¹®¼º Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. Àǽİú ÀÇÇÐÀû Àü¹® Áö½ÄÀÌ °è¼Ó ¹ßÀüÇϰí ÀÖ´Â °¡¿îµ¥, »õ·Î¿î Áú ¼ö¼úÀº Àç°ÇÀû °³ÀÔÀ» ¿øÇÏ´Â »ç¶÷µé¿¡°Ô ½ÅüÀû, ½É¸®Àû ÀÌÁ¡À» Á¦°øÇÏ´Â »îÀ» º¯È­½ÃŰ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

»õ·Î¿î Áú ¼ö¼ú ½ÃÀåÀÌ Á÷¸éÇÑ °úÁ¦´Â?

»õ·Î¿î Áú ¼ö¼ú ½ÃÀåÀº ±× Á߿伺ÀÌ Ä¿Áö°í ÀÖÀ½¿¡µµ ºÒ±¸Çϰí Á¢±Ù¼º, Ä¡·á °á°ú, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀο¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¸î °¡Áö °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. °¡Àå Å« À庮 Áß Çϳª´Â Áú ¼ºÇü¼ú ¹× ±âŸ Àç°Ç ¼ö¼úÀ» Àü¹®À¸·Î ÇÏ´Â °íµµ·Î ÈÆ·ÃµÈ ¿Ü°ú ÀÇ»çÀÇ ¼ö°¡ Á¦ÇÑÀûÀ̶ó´Â Á¡ÀÔ´Ï´Ù. ½Ã¼úÀÌ º¹ÀâÇϹǷΠ±¤¹üÀ§ÇÑ ¿Ü°úÀû Àü¹® Áö½ÄÀÌ ÇÊ¿äÇϸç, Àü¹® ÀÇ·á¼¾ÅͰ¡ ¾Æ´Ï¸é ÀÌ¿ëÇÒ ¼ö ¾ø½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ ¼ö¼ú°ú °ü·ÃµÈ °í°¡ÀÇ ºñ¿ëÀº ¸¹Àº ȯÀڵ鿡°Ô °æÁ¦Àû ¾î·Á¿òÀ» ¾ß±âÇϰí ÀÖÀ¸¸ç, ƯÈ÷ Á¨´õ ±àÁ¤ Ä¡·á ¹× Àç°Ç ¼ö¼úÀÌ º¸Çè Àû¿ëÀÌ µÇÁö ¾Ê´Â Áö¿ª¿¡¼­´Â ÀÌ·¯ÇÑ ¹®Á¦°¡ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ ¹®Á¦´Â ÇùÂø, °¨¿°, ±â´É Á¦ÇÑ µîÀÇ ¼ö¼ú ÈÄ ÇÕº´Áõ À§ÇèÀ̸ç, ÀÌ´Â Àå±â°£ÀÇ °æ°ú °üÂû°ú °ü¸®°¡ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ ¼ö¼ú ÈÄ ÀçȰġ·á¿¡ ´ëÇÑ Ç¥ÁØÈ­µÈ ÇÁ·ÎÅäÄÝÀÌ Á¸ÀçÇÏÁö ¾Ê¾Æ ȯÀÚ °á°ú¿¡ Â÷À̰¡ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. À±¸®Àû, ¹ýÀû °í·Á»çÇ× ¶ÇÇÑ ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÏ´Â ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¼ºÀüȯ ¼ö¼ú¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ¼ö¿ëµµ°¡ ±¹°¡¸¶´Ù ´Ù¸£±â ¶§¹®ÀÔ´Ï´Ù. Æ®·£½ºÁ¨´õÀÇ ÀÇ·á ¹× Àç°Ç ¼ö¼ú°ú °ü·ÃµÈ ³«ÀÎÀº Á¢±Ù¼ºÀ» ´õ¿í Á¦ÇÑÇϰí, ÀϺΠ»ç¶÷µéÀº ÇÊ¿äÇÑ ÀÇ·á ¼­ºñ½º¸¦ ¹ÞÁö ¾ÊÀ¸·Á´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â ÀÇ·á ±â¼ú Çõ½Å»Ó¸¸ ¾Æ´Ï¶ó Á¤Ã¥ °³Çõ, ¿Ü°ú ÀÇ»çÀÇ ¼ö·Ã ±âȸ Áõ°¡, Àç°Ç ¼ö¼ú°ú¼º Á¤Ã¼¼º À¯Áö ¼ö¼ú¿¡ ´ëÇÑ »çȸÀû ¼ö¿ë¼º È®´ë°¡ ÇÊ¿äÇÕ´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô »õ·Î¿î Áú ¼ö¼úÀ» À籸¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº »õ·Î¿î Áú ¼ö¼úÀÇ Á¤È®¼º, ¾ÈÀü¼º, À¯È¿¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ·Îº¿ º¸Á¶ ¼ö¼úÀÇ ÅëÇÕÀº º¹ÀâÇÑ ¼ö¼úÀÇ Á¤È®µµ¸¦ ³ôÀ̰í, ȸº¹ ½Ã°£À» ´ÜÃàÇϸç, ±âÁ¸ ¼ö¼ú¿¡ ¼ö¹ÝµÇ´Â À§ÇèÀ» ÃÖ¼ÒÈ­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¶Á÷°øÇаú Àç»ý ÀÇÇÐÀÇ ¹ßÀüÀº ±â´ÉÀûÀÌ°í »ý¹°ÇÐÀûÀ¸·Î ÀûÇÕÇÑ »õ·Î¿î Áú ±¸Á¶¸¦ ¸¸µé±â À§ÇÑ À¯¸Á ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. Áٱ⼼Æ÷ Ä¡·á¿Í »ýü°øÇÐ Áú Á¶Á÷¿¡ ´ëÇÑ ¿¬±¸´Â Àå±âÀûÀÎ ¼ö¼ú °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ´Â »õ·Î¿î °¡´É¼ºÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Çõ½ÅÀûÀÎ ¹ßÀüÀº ¼ö¼ú Àü °èȹ°ú ȯÀÚº° ¼ö¼ú °¡À̵忡 3D ÇÁ¸°Å͸¦ Ȱ¿ëÇÔÀ¸·Î½á ÇØºÎÇÐÀû ¸ÂÃãÈ­°¡ °¡´ÉÇØÁ® ¼ö¼úÀÇ Á¤È®µµ°¡ Çâ»óµÇ¾ú½À´Ï´Ù´Â Á¡ÀÔ´Ï´Ù. ÅëÁõ °ü¸® °­È­ ¹× È®Àå ±â¼ú ÃÖÀûÈ­ µî ¼ö¼ú ÈÄ °ü¸® Àü·«ÀÇ °³¼±À¸·Î ȯÀÚ °æÇè°ú ±â´ÉÀû ¼º°ø·üÀÌ ´õ¿í Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿ø°ÝÀÇ·á ¹× µðÁöÅÐ °Ç°­ Ç÷§ÆûÀÇ µîÀåÀ¸·Î Áú¼ºÇü ¼ö¼ú ȯÀÚÀÇ ¼ö¼ú Àü °Ë»ç, ¼ö¼ú ÈÄ ¸ð´ÏÅ͸µ ¹× Á¤½Å°Ç°­ Áö¿ø¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¼ö¼ú ´É·ÂÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó, »õ·Î¿î Áú ¼ö¼ú ºÐ¾ßÀÇ Á¢±Ù¼º°ú ȯÀÚ Áß½ÉÀÇ Ä¡·á¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

»õ·Î¿î Áú ¼ö¼ú ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

»õ·Î¿î Áú ¼ö¼ú ½ÃÀåÀÇ ¼ºÀåÀº ¼ºÀüȯ ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¼ö¼ú ±â¼úÀÇ ¹ßÀü, ÀÇ·á Á¤Ã¥ÀÇ °³¼± µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Æ®·£½ºÁ¨´õÀÇ ÀÇ·áÀû ¿ä±¸°¡ ÀÎ½ÄµÇ°í ¼ö¿ëµÇ¸é¼­ Áú ¼ºÇü¼ú ¹× ±âŸ ¼ºÀüȯ ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ Á¦°øÇÏ´Â ¼ö¼úÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ MRKH ÁõÈıº°ú °°Àº ¼±Ãµ¼º Áúȯ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Áú Àç°ÇÀÌ ÇÊ¿äÇÑ °³Àο¡ ´ëÇÑ ÀÇ·á °³ÀÔÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿©·¯ ±¹°¡¿¡¼­ º¸Çè Àû¿ë ¹üÀ§°¡ È®´ëµÇ°í, Á¤ºÎ Áö¿ø ÀÇ·á ¼­ºñ½ºµµ ÀÌ·¯ÇÑ ¼ö¼úÀ» °æÁ¦ÀûÀ¸·Î ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀü, ƯÈ÷ ·Îº¿ º¸Á¶ ¼ö¼ú°ú »ýü °øÇÐ Á¶Á÷ÀÇ ¹ßÀüÀº ¼ö¼ú °á°ú¸¦ ´õ¿í Çâ»ó½Ã۰í ÇÕº´ÁõÀ» °¨¼Ò½ÃÄÑ ´õ ¸¹Àº ȯÀÚ°¡ ÀÌ·¯ÇÑ °³ÀÔÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. Àü¹® ¼ö¼ú¼¾ÅÍ¿Í ´ÙÇÐÁ¦ ÀÇ·áÆÀÀÇ ³×Æ®¿öÅ©°¡ È®´ëµÊ¿¡ µû¶ó Àü¹ÝÀûÀÎ Ä¡·áÀÇ ÁúÀÌ Çâ»óµÇ°í ¼ö¼ú ¿É¼Ç¿¡ ´ëÇÑ ½Å·Ú°¡ ³ô¾ÆÁ³½À´Ï´Ù. ¼º ´Ù¾ç¼º°ú Àç°Ç ¼ö¼ú¿¡ ´ëÇÑ »çȸÀû ÀνÄÀÌ °è¼Ó ÁøÈ­ÇÔ¿¡ µû¶ó »õ·Î¿î Áú ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ÀÌ Àü¹® ÀÇ·á ºÐ¾ßÀÇ Ãß°¡ Çõ½Å°ú ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

Ä¡·á À¯Çü(¼ºº° ÀûÇÕ ¼ö¼ú, ÁúÇü¼º ºÎÀü Ä¡·á ¼ö¼ú, ÁúÆó¼âÁõ Ä¡·á ¼ö¼ú)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø·Î ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Neovaginal Surgery Market to Reach US$1.5 Billion by 2030

The global market for Neovaginal Surgery estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Sex Reassignment Surgery, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$837.9 Million by the end of the analysis period. Growth in the Vaginal Agenesis Treatment Surgery segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$333.0 Million While China is Forecast to Grow at 7.1% CAGR

The Neovaginal Surgery market in the U.S. is estimated at US$333.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$309.9 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Neovaginal Surgery Market - Key Trends & Drivers Summarized

Why Is Neovaginal Surgery Gaining Significance in Modern Medicine?

Neovaginal surgery, a highly specialized branch of reconstructive and gender-affirming surgery, is becoming increasingly important as medical advancements expand options for individuals requiring vaginal reconstruction. This surgical procedure is performed for various medical and personal reasons, including gender-affirming procedures for transgender women, congenital conditions such as Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome, and reconstructive needs following trauma or oncological treatments. The evolution of surgical techniques has significantly improved outcomes, with approaches ranging from penile inversion vaginoplasty and intestinal vaginoplasty to non-surgical options such as tissue expansion and vaginoplasty using autologous skin grafts. Advancements in surgical materials and postoperative care have enhanced functionality, aesthetic outcomes, and patient satisfaction. The growing acceptance and recognition of transgender healthcare have also contributed to the rising demand for neovaginal procedures, leading to increased specialization in this medical field. As awareness and medical expertise continue to evolve, neovaginal surgery is providing life-changing solutions for individuals seeking reconstructive interventions, offering both physical and psychological benefits.

What Are the Challenges Facing the Neovaginal Surgery Market?

Despite its growing importance, the neovaginal surgery market faces several challenges that impact accessibility, procedural outcomes, and regulatory approvals. One of the most significant barriers is the limited availability of highly trained surgeons specializing in vaginoplasty and other reconstructive techniques. The complexity of the procedure requires extensive surgical expertise, making it accessible only in specialized medical centers. Additionally, the high cost associated with these surgeries poses financial challenges for many patients, particularly in regions where gender-affirming care or reconstructive surgeries are not covered by insurance. Another challenge is the risk of postoperative complications, including stenosis, infections, and functional limitations, which require long-term follow-up and care. Furthermore, there is a persistent lack of standardized protocols for post-surgical rehabilitation, leading to variability in patient outcomes. Ethical and legal considerations also play a role in limiting market growth, as different countries have varying levels of regulatory acceptance regarding gender-affirming surgeries. The stigma associated with transgender healthcare and reconstructive procedures further restricts access and discourages some individuals from seeking necessary medical care. Addressing these challenges requires not only medical innovation but also policy reforms, increased training opportunities for surgeons, and broader societal acceptance of reconstructive and gender-affirming procedures.

How Are Technological Advancements Reshaping Neovaginal Surgery?

Technological advancements are playing a pivotal role in improving the precision, safety, and effectiveness of neovaginal surgery. The integration of robotic-assisted surgery is enhancing the accuracy of complex procedures, reducing recovery times, and minimizing risks associated with traditional surgical techniques. Additionally, advancements in tissue engineering and regenerative medicine are offering promising solutions for creating functional and biologically compatible neovaginal structures. Research into stem cell therapies and bioengineered vaginal tissues has opened new possibilities for improving long-term surgical outcomes. Another transformative development is the use of 3D printing for pre-surgical planning and patient-specific surgical guides, allowing for better anatomical customization and improved surgical accuracy. Improved postoperative care strategies, including enhanced pain management and optimized dilation techniques, are further enhancing patient experience and functional success rates. Moreover, the rise of telemedicine and digital health platforms is increasing access to preoperative consultations, postoperative monitoring, and mental health support for patients undergoing neovaginal procedures. These technological innovations are not only advancing surgical capabilities but also improving accessibility and patient-centered care in the field of neovaginal surgery.

What Is Driving the Growth of the Neovaginal Surgery Market?

The growth in the neovaginal surgery market is driven by several factors, including increasing demand for gender-affirming procedures, advancements in surgical techniques, and improved healthcare policies. The rising visibility and acceptance of transgender healthcare needs have led to a surge in demand for vaginoplasty and other gender-affirming surgeries, prompting healthcare providers to expand their offerings. Additionally, congenital conditions such as MRKH syndrome are becoming more widely recognized, leading to increased medical interventions for individuals requiring vaginal reconstruction. The expansion of insurance coverage and government-backed healthcare initiatives in various countries is also making these procedures more financially accessible. Technological advancements, particularly in robotic-assisted surgery and bioengineered tissues, are further enhancing surgical outcomes and reducing complications, attracting more patients to seek these interventions. The growing network of specialized surgical centers and multidisciplinary healthcare teams is improving the overall quality of care, fostering greater confidence in surgical options. As societal attitudes toward gender diversity and reconstructive surgery continue to evolve, the demand for neovaginal procedures is expected to increase, driving further innovation and market expansion in this specialized field of medicine.

SCOPE OF STUDY:

The report analyzes the Neovaginal Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery, Vaginal Atresia Treatment Surgery)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â